Replies to post #690016 on NorthWest Biotherapeutics Inc (NWBO)

[DJPele]

Small sample size perhaps? The study wasn't geared to monitor OS. OS just happened to be a beneficial outcome.

I would assume a full blown PHIII trial would make more headlines. Regardless, this study is good news.